MF
Motti Frimer
Vice President Digital Solutions, R&D, and Managing Director of Asensus Surgical Israel
Asensus SurgicalTherapeutic Areas
Asensus Surgical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Senhance® Surgical System | Robotic-Assisted Laparoscopic Surgery | Approved/Commercial |
| Intelligent Surgical Unit™ (ISU™) | Augmented Intelligence for Surgical Guidance | Approved/Commercial |
| Senhance® for Pediatric Surgery | Pediatric Robotic-Assisted Procedures | Commercial |
| Senhance® for TEP Hernioplasty | Totally Extraperitoneal Hernia Repair | Clinical Expansion |
| Senhance® for Inguinal Hernia Repair | Inguinal Hernia | Clinical Expansion |
| Senhance® for Radical Prostatectomy | Robot-Assisted Radical Prostatectomy | Clinical Expansion |
| Senhance® for Oncology | Robotic Surgery in Oncological Procedures | Clinical Expansion |
Leadership Team at Asensus Surgical
AF
Anthony Fernando
President & Chief Executive Officer
DE
Dr. Ed Chekan
Vice President, Medical Affairs & Professional Education
KF
Kathleen Frost
Vice President, Intellectual Property
RK
Ravi Kommineni
Vice President, Quality and Regulatory
WL
Wesley Long
Vice President, Customer Excellence
KN
Ken Nicolosi
Director of U.S. Sales and Clinical Operations
DO
Daniel Odermatt
Vice President, Global Marketing
DP
Daniel Potts
Vice President, Asia Pacific
BS
Brian Stellmach
Vice President, Digital Solutions
NS
Nicholas Summitt
Vice President, Strategy and Development